{"ticker": {"uuid": "8cd97599-ad6b-4ba9-9cdd-c5a3b9e0ab13", "symbol": "TAKP34", "name": "Takeda Pharmaceutical Company Limited", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Form 144 Takeda Pharmaceutical Company Limited For: 13 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPOFZSMF8tV1NmRzNNakZqT3Q0eVVTMXdfU0hDOE1UWU03UjhaakxxdmdKTVhMd3p4aUswc0JwSDdmOUdyRGxGNk5qdUduY0hKQ1FzbkMzbmtCNURMMm1menE1VnlaMi1iY0hzT0xXVEtldVcwb3VZLUhTNmo3VjBjb19WUThNLWQ0a19Zc0pDQXN4elltSHIyQ1FMWXFXaUcxdmVPYmFsREVOVEtUck84UnR5TlAxTnZXeVJF?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-13T11:37:16+00:00", "published_display": "13 Jul 2026 11:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Crist\u00e1lia-Takeda plant deal cleared in Brazil", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQZE1sbjJrUG80cG9hbWs1MWxhNE9Nb2d3clA0WTZ2M2V5bHNDTEU3dzBfbWR3WEttZWxpQk4wNzV2NnVPd3pXSWs1NTdkSEUwSEYtTmtKX3hjR2t1eG55dE1fSGk0VERnRDJPODRwdmNVVTdkV3JidjFCSzNDbkduWUY1cU9OeUJ2bkFOd3ptV3QzZ9IBWkFVX3lxTFB2TGJ4VjdKX3dfOEJ5V0tzZVlxdnVZa25oOGw5d0lMamdwSWxfZHA0MTdzMWx4RmhFZTl1WEZDXzNDZjFucXgxYUY3NDA5SlFDLXBnOWg3M1BGdw?oc=5", "source_name": "MLex", "published_at": "2026-07-03T14:46:00+00:00", "published_display": "03 Jul 2026 14:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (NYSE: TAK) outlines FY2025 results, pipeline launches and ESG progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOUHh3ZkF3NjZCZFBNZzc1d2tfWHQwZEptUzdVUjU3T2FlenZITk5GcHRvZ3BORUhid1RoOC11NDZ2ZmlhN1Vyc21MeVhqY2lfZ25fSDE4bjlKLVRQc0QzdkFJVm4xdkRyQnAtNmZCYjd6ZC1acEtVdzUzRzBvazlGNGl0V21YOE1OODVUdHRCekphajF6RXZuNEVralE0UjcwWFFiUHRvdllsOC02Q2dOR2l4dGZPdnVFS1JoY3lHTzk?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Demand shift appears to complicate Crist\u00e1lia-Takeda plant deal scrutiny in Brazil", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQbjBYY2lJMUZTSFFGeXRqdFI3RE9Bdi1fYlp4YnhZMk5PSHkxVXl4bGZXakNHTkdxNE83aWNWX1BldjMzRFJXVXV4Zk8tRFNoSERaMlYxeGowdUdFVFZvRVVBaVBOZ1ROTlY1S2dhSUljb205UEpERGZUQVpXbEtmOGxHdl9lT3U0ejNlR1ZaUzZiakR4dU1rNU1ZdUp6QmJ4ZTNpS3ZKLVJQd2NwNXU1dGhTTVJ0TWNvY1VtdWtKSmFnQdIBWkFVX3lxTE9ScUVMNHVfUXlVYmJLMWUxemdDX0EzSktzZHVZNGJTWVlKVEs0cDljQjBHazhVbEVFVkR4SnVwYUczdXZuZFpfQTdSN3hVTGZJOUVhNDRUZWQ4dw?oc=5", "source_name": "MLex", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Q4 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNMDhSMGR0Z2o5T2hPMDFiLUl1RGtodWs0dFRrNEwwZVNOdjZBUUtGclVmQ2hrY3kzeVI2bVNYOGcxakhFbklWUXVkVGdEOU93YUlVX3JhQWJvcVRSNnM4S3FteTBIemgwOE8tVndFWG5tZzdZQnExZVRmY2VYNGo2UUJOOTFaS240MXdaM2gwSlVLUDNOVG1FdGN1UXJuTlhqV1VNZnhOb0NCbzg?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Takeda\u2019s Q4 2025 performance highlights resilience", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOZVExUUJEYnE5VzAybjgyOU15UTlkZGF4OUlqZmVkZC00TlBhaFFZc2FoUl93akNWbzdsSEdVOHREY0ZjRTVSaTZJSW1TMTV6Mmxyc0dtYTZQNEU1Zm5yZ1VSWUx0QkRYQjQxNkRZVXhzbWVfYkxQT2I0dHVZalgwSXhBLU1fQjZWZWhVWWlydlJjRmxUWTlVNldkdFhQQlhyQmFPU3Y1eG5PTDVKaXNOOVVka3cwOUdmeDc0VDh3eVJuV19ubUNWZzFR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil Pharmaceutical Market Size & Outlook, 2026-2033", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPLXZfRHdGb3ZPVGFkT2c3MENka2w2MVJDY2FoczBfazc0dHFMeWtjcEF0MzNuczllX3hhamhoenBJMDJIRUZWdk9heVI2UXVNWTE3bU1yWXVPTExDRVhlQnNEUEN2RVNkSVNYN1NaRTkwV252aDl4QjRlUUxfcTFfamVqQ00?oc=5", "source_name": "Grand View Research", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Latin America Pharmaceutical Market Size & Growth, 2034", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOYXRyM2kzazVkM2pqb3VBWHlNUVl3R1g2cmMyQS1kVjFGT2tPcVg5WnByS1I2MFF5aEpkZU5qczNJWE40Qkwtbzl6Z01lVUJlMzdZSUlaZXNnVksxN19ZX3FZMUdrZEpaWm5EVm5EMFl5ZTg4WWNJVlZYSGVoWi16QUJFN1FacnZicVpvaEhB?oc=5", "source_name": "Market Data Forecast", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Takeda beats Q3 2025 forecasts, stock climbs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPY0dfWGRYRDFzZjVvMW5TdTNHeVhYQ0hNNjN0SllVcWFaak5JYnJTcmRscW1OMzFDSTNGUzRxZVQyN3Y5TENNME9hNkNnSUhTbVN5SmlkWV9IUkcwVkdTRzBqWmotYmhZNWU3SmNaUktEeDNDZDRRZHhteUNyWHRmWkpDbVE1UHBtME1GaG12bThkTlNBTmhzR0kwNzIwYTJCTlVHWE8wWk1qYUNmYUdGMXdPd2FoOEU2SDIzM25FdFd0UQ?oc=5", "source_name": "Investing.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Phase 3 Data Show Takeda\u2019s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxOVFMyTW1VNVpmTk94dXB6UkUyZHYxUlBlNXZja1BrSmlaek95MnNDUF9VbGU3STR4d3g1MDM5Z2gtNjhyNF9CYTBoSFdXZmljSnl5OTNDc25wNEh2bzFLTVcwWUlwRHpqTGtmdzRxMmlTZUdSMGFlR3JVcE9RM2pVR0VPOG5ESnFzNzlvVWZoRnEzSF9vVHQ3UGdUcUR0M0hSYlRCcUpTRDVPc2dhYXJjaUc5TTlid3NvbTRnWmhoYXdXUGpScUtGMWNlZlRpWjlOMzQ4cVJzZ0phM09QbXlxR0pHRFVPeUFIS3lxRWZiajNaRVRsanc?oc=5", "source_name": "BioSpace", "published_at": "2025-11-04T08:00:00+00:00", "published_display": "04 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda\u2019s dengue vaccine shows long-lasting protection", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQUFRlckRnYm9mRFVxYnVDZXpSNFRVa3pTRzV5ancxS2g4SjVxY0hudmRZY0p2Y05MU2h4YVB2aWlaRmI5c3dyX0JLcjRLUzU5emJXR3M2Y3BVVUg2UkhwZmF2NFNaang2R3hTRXVZbUYwRzFpZnN2aHYwSkZQd3FHeHZtaENXeTI5?oc=5", "source_name": "The Japan Times", "published_at": "2025-11-04T08:00:00+00:00", "published_display": "04 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Offers Dengue Shot Cheaper in Brazil, Indonesia", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNcEwzX21ZU0tFNVpVTkI1ZV9DNUdYLU1paHlPSGFpZThBU3NmQW1IMGc2eFctbUg2WldBSmg0c1pTY1d4bXdUalhCNjFOSUFFLWxHWnV4ZEE4QXU3Ym42cC1OWW1lR2czUmdTTUI0aGpGVXR2YTNHQ09ZODRJa2VmNGNlWXNtZmw5ajdBUnBEbjdzV3h3YVZXY9IBrAFBVV95cUxOLV9BcXYtUjJONnROWDNLa3ZVelJhZV9UMTZGT0FoeGtIazNjMWgxU0RUSFpXb1IwekU2SFNjbG1paElGcHl4RmJxRFNQaTJNNUtKLXVIRlpWZWZrcHNDOVhVZUpGTTNxaTNmZkVRYXFlRkFvR3J5M3Z0WjZuR01xT1lVd3h3UDlXVkI3WE9FT0tIRFllOGpRc0x3anVwd2d1NUEyNURZLVE2R2hY?oc=5", "source_name": "Bloomberg L\u00ednea", "published_at": "2023-03-04T08:00:00+00:00", "published_display": "04 Mar 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil's Hypera Pharma to acquire drugs from Japan's Takeda for $825 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWXVxWVhVT3pFcmc0dy1acEFVWFpQbUpsMENXb1BGZzRLemFBMlphcjlKcjBLZXlMWG8taldQdzVXSnJITE5iVjdmQjEtQ0IwaWdoR0hHc005NDNwem82REh6NDJTLUVmQXVFcWxJUGE3c2Nta3dqbDRlOTV2SjBQSjNoRXFiRm9Fbk1CcEZRZENoX3hDZ0FoRFN0Wko4WjRBZmZSODh2M3p5TkRzbU5RNFJBUkhITmJrNVBEX3pzMXQ2VmstOXg5U19LRTdKbWhYX0lralNJeHZfQXlreVZ3aVYtQzc2NERmMzFtSQ?oc=5", "source_name": "Reuters", "published_at": "2020-03-02T08:00:00+00:00", "published_display": "02 Mar 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd (TAK) Stock Price, Trades & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE9POWNHaFFMU3JucHJoNjJfcHVFMnZWTUlieFRoLTlDdlhmZ0NyZklrTWxDYS1zZFpsZWFQSTZlTHhkc2dCamxsckhPZHVPMmVfQ19QNldR?oc=5", "source_name": "GuruFocus", "published_at": "2019-04-17T20:16:21+00:00", "published_display": "17 Apr 2019 20:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Form 144 Takeda Pharmaceutical Company Limited For: 13 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPOFZSMF8tV1NmRzNNakZqT3Q0eVVTMXdfU0hDOE1UWU03UjhaakxxdmdKTVhMd3p4aUswc0JwSDdmOUdyRGxGNk5qdUduY0hKQ1FzbkMzbmtCNURMMm1menE1VnlaMi1iY0hzT0xXVEtldVcwb3VZLUhTNmo3VjBjb19WUThNLWQ0a19Zc0pDQXN4elltSHIyQ1FMWXFXaUcxdmVPYmFsREVOVEtUck84UnR5TlAxTnZXeVJF?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-13T11:37:16+00:00", "published_display": "13 Jul 2026 11:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Crist\u00e1lia-Takeda plant deal cleared in Brazil", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQZE1sbjJrUG80cG9hbWs1MWxhNE9Nb2d3clA0WTZ2M2V5bHNDTEU3dzBfbWR3WEttZWxpQk4wNzV2NnVPd3pXSWs1NTdkSEUwSEYtTmtKX3hjR2t1eG55dE1fSGk0VERnRDJPODRwdmNVVTdkV3JidjFCSzNDbkduWUY1cU9OeUJ2bkFOd3ptV3QzZ9IBWkFVX3lxTFB2TGJ4VjdKX3dfOEJ5V0tzZVlxdnVZa25oOGw5d0lMamdwSWxfZHA0MTdzMWx4RmhFZTl1WEZDXzNDZjFucXgxYUY3NDA5SlFDLXBnOWg3M1BGdw?oc=5", "source_name": "MLex", "published_at": "2026-07-03T14:46:00+00:00", "published_display": "03 Jul 2026 14:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (NYSE: TAK) outlines FY2025 results, pipeline launches and ESG progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOUHh3ZkF3NjZCZFBNZzc1d2tfWHQwZEptUzdVUjU3T2FlenZITk5GcHRvZ3BORUhid1RoOC11NDZ2ZmlhN1Vyc21MeVhqY2lfZ25fSDE4bjlKLVRQc0QzdkFJVm4xdkRyQnAtNmZCYjd6ZC1acEtVdzUzRzBvazlGNGl0V21YOE1OODVUdHRCekphajF6RXZuNEVralE0UjcwWFFiUHRvdllsOC02Q2dOR2l4dGZPdnVFS1JoY3lHTzk?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Demand shift appears to complicate Crist\u00e1lia-Takeda plant deal scrutiny in Brazil", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQbjBYY2lJMUZTSFFGeXRqdFI3RE9Bdi1fYlp4YnhZMk5PSHkxVXl4bGZXakNHTkdxNE83aWNWX1BldjMzRFJXVXV4Zk8tRFNoSERaMlYxeGowdUdFVFZvRVVBaVBOZ1ROTlY1S2dhSUljb205UEpERGZUQVpXbEtmOGxHdl9lT3U0ejNlR1ZaUzZiakR4dU1rNU1ZdUp6QmJ4ZTNpS3ZKLVJQd2NwNXU1dGhTTVJ0TWNvY1VtdWtKSmFnQdIBWkFVX3lxTE9ScUVMNHVfUXlVYmJLMWUxemdDX0EzSktzZHVZNGJTWVlKVEs0cDljQjBHazhVbEVFVkR4SnVwYUczdXZuZFpfQTdSN3hVTGZJOUVhNDRUZWQ4dw?oc=5", "source_name": "MLex", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Q4 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNMDhSMGR0Z2o5T2hPMDFiLUl1RGtodWs0dFRrNEwwZVNOdjZBUUtGclVmQ2hrY3kzeVI2bVNYOGcxakhFbklWUXVkVGdEOU93YUlVX3JhQWJvcVRSNnM4S3FteTBIemgwOE8tVndFWG5tZzdZQnExZVRmY2VYNGo2UUJOOTFaS240MXdaM2gwSlVLUDNOVG1FdGN1UXJuTlhqV1VNZnhOb0NCbzg?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Takeda\u2019s Q4 2025 performance highlights resilience", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOZVExUUJEYnE5VzAybjgyOU15UTlkZGF4OUlqZmVkZC00TlBhaFFZc2FoUl93akNWbzdsSEdVOHREY0ZjRTVSaTZJSW1TMTV6Mmxyc0dtYTZQNEU1Zm5yZ1VSWUx0QkRYQjQxNkRZVXhzbWVfYkxQT2I0dHVZalgwSXhBLU1fQjZWZWhVWWlydlJjRmxUWTlVNldkdFhQQlhyQmFPU3Y1eG5PTDVKaXNOOVVka3cwOUdmeDc0VDh3eVJuV19ubUNWZzFR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil Pharmaceutical Market Size & Outlook, 2026-2033", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPLXZfRHdGb3ZPVGFkT2c3MENka2w2MVJDY2FoczBfazc0dHFMeWtjcEF0MzNuczllX3hhamhoenBJMDJIRUZWdk9heVI2UXVNWTE3bU1yWXVPTExDRVhlQnNEUEN2RVNkSVNYN1NaRTkwV252aDl4QjRlUUxfcTFfamVqQ00?oc=5", "source_name": "Grand View Research", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Latin America Pharmaceutical Market Size & Growth, 2034", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOYXRyM2kzazVkM2pqb3VBWHlNUVl3R1g2cmMyQS1kVjFGT2tPcVg5WnByS1I2MFF5aEpkZU5qczNJWE40Qkwtbzl6Z01lVUJlMzdZSUlaZXNnVksxN19ZX3FZMUdrZEpaWm5EVm5EMFl5ZTg4WWNJVlZYSGVoWi16QUJFN1FacnZicVpvaEhB?oc=5", "source_name": "Market Data Forecast", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Takeda beats Q3 2025 forecasts, stock climbs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPY0dfWGRYRDFzZjVvMW5TdTNHeVhYQ0hNNjN0SllVcWFaak5JYnJTcmRscW1OMzFDSTNGUzRxZVQyN3Y5TENNME9hNkNnSUhTbVN5SmlkWV9IUkcwVkdTRzBqWmotYmhZNWU3SmNaUktEeDNDZDRRZHhteUNyWHRmWkpDbVE1UHBtME1GaG12bThkTlNBTmhzR0kwNzIwYTJCTlVHWE8wWk1qYUNmYUdGMXdPd2FoOEU2SDIzM25FdFd0UQ?oc=5", "source_name": "Investing.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Phase 3 Data Show Takeda\u2019s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxOVFMyTW1VNVpmTk94dXB6UkUyZHYxUlBlNXZja1BrSmlaek95MnNDUF9VbGU3STR4d3g1MDM5Z2gtNjhyNF9CYTBoSFdXZmljSnl5OTNDc25wNEh2bzFLTVcwWUlwRHpqTGtmdzRxMmlTZUdSMGFlR3JVcE9RM2pVR0VPOG5ESnFzNzlvVWZoRnEzSF9vVHQ3UGdUcUR0M0hSYlRCcUpTRDVPc2dhYXJjaUc5TTlid3NvbTRnWmhoYXdXUGpScUtGMWNlZlRpWjlOMzQ4cVJzZ0phM09QbXlxR0pHRFVPeUFIS3lxRWZiajNaRVRsanc?oc=5", "source_name": "BioSpace", "published_at": "2025-11-04T08:00:00+00:00", "published_display": "04 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda\u2019s dengue vaccine shows long-lasting protection", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQUFRlckRnYm9mRFVxYnVDZXpSNFRVa3pTRzV5ancxS2g4SjVxY0hudmRZY0p2Y05MU2h4YVB2aWlaRmI5c3dyX0JLcjRLUzU5emJXR3M2Y3BVVUg2UkhwZmF2NFNaang2R3hTRXVZbUYwRzFpZnN2aHYwSkZQd3FHeHZtaENXeTI5?oc=5", "source_name": "The Japan Times", "published_at": "2025-11-04T08:00:00+00:00", "published_display": "04 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Offers Dengue Shot Cheaper in Brazil, Indonesia", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNcEwzX21ZU0tFNVpVTkI1ZV9DNUdYLU1paHlPSGFpZThBU3NmQW1IMGc2eFctbUg2WldBSmg0c1pTY1d4bXdUalhCNjFOSUFFLWxHWnV4ZEE4QXU3Ym42cC1OWW1lR2czUmdTTUI0aGpGVXR2YTNHQ09ZODRJa2VmNGNlWXNtZmw5ajdBUnBEbjdzV3h3YVZXY9IBrAFBVV95cUxOLV9BcXYtUjJONnROWDNLa3ZVelJhZV9UMTZGT0FoeGtIazNjMWgxU0RUSFpXb1IwekU2SFNjbG1paElGcHl4RmJxRFNQaTJNNUtKLXVIRlpWZWZrcHNDOVhVZUpGTTNxaTNmZkVRYXFlRkFvR3J5M3Z0WjZuR01xT1lVd3h3UDlXVkI3WE9FT0tIRFllOGpRc0x3anVwd2d1NUEyNURZLVE2R2hY?oc=5", "source_name": "Bloomberg L\u00ednea", "published_at": "2023-03-04T08:00:00+00:00", "published_display": "04 Mar 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil's Hypera Pharma to acquire drugs from Japan's Takeda for $825 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWXVxWVhVT3pFcmc0dy1acEFVWFpQbUpsMENXb1BGZzRLemFBMlphcjlKcjBLZXlMWG8taldQdzVXSnJITE5iVjdmQjEtQ0IwaWdoR0hHc005NDNwem82REh6NDJTLUVmQXVFcWxJUGE3c2Nta3dqbDRlOTV2SjBQSjNoRXFiRm9Fbk1CcEZRZENoX3hDZ0FoRFN0Wko4WjRBZmZSODh2M3p5TkRzbU5RNFJBUkhITmJrNVBEX3pzMXQ2VmstOXg5U19LRTdKbWhYX0lralNJeHZfQXlreVZ3aVYtQzc2NERmMzFtSQ?oc=5", "source_name": "Reuters", "published_at": "2020-03-02T08:00:00+00:00", "published_display": "02 Mar 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd (TAK) Stock Price, Trades & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE9POWNHaFFMU3JucHJoNjJfcHVFMnZWTUlieFRoLTlDdlhmZ0NyZklrTWxDYS1zZFpsZWFQSTZlTHhkc2dCamxsckhPZHVPMmVfQ19QNldR?oc=5", "source_name": "GuruFocus", "published_at": "2019-04-17T20:16:21+00:00", "published_display": "17 Apr 2019 20:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 54, "total_relevant": 14, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 12, "score": 52, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 4.55, "count": 7}, {"event": "earnings", "label": "Earnings", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 82.32, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 7.9, "twelve_week_move": -8.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.66895, "market_dynamics_buy_signal": false, "relative_strength": -7.688184, "fair_value_gap": 9.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.9515, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +7.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MLex", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Market source", "count": 1}, {"label": "Grand View Research", "count": 1}, {"label": "Market Data Forecast", "count": 1}, {"label": "BioSpace", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 7}, {"label": "Earnings", "count": 4}, {"label": "Deals and strategy", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, +7.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Form 144 Takeda Pharmaceutical Company Limited For: 13 July By Investing.com"}], "updated_at": "2026-07-17T18:48:35.636502+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}